The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
Hereditary Hemochromatosis — A New Look at an Old Disease
Abstract
For many years, hereditary hemochromatosis was regarded as a clinically and genetically unique entity marked by a classic presentation consisting of diabetes, bronze skin pigmentation, and cirrhosis. In 1996, identification of “the hemochromatosis gene,” HFE, was reported; since then, several other iron-metabolism genes have also been identified. This article reviews the current understanding and management of hereditary iron-overload disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The HFE mutation leads to an impaired formation of hepcidin and thus to an iron deficiency phenotype of MΦs, whereas excessively absorbed iron is stored in parenchymal organs such as the liver, heart, or pancreas.”
From Macrophage defense mechanisms against intracellular bacteria (2015) · cites this paper as [201]
In the citing paper
“Conversely, individuals with insufficient hepcidin production, suffer from iron-overload in the blood, and hepatitis (Pietrangelo, 2004).”
From The Role of Iron Regulation in Immunometabolism and Immune-Related Disease (2019) · cites this paper as Pietrangelo, 2004
In the citing paper
“HFE mutations, especially the homozygous C282Y substitution, result in type I (AKA classical) hereditary hemochromatosis (HH) (Camaschella et al., 2002; Pietrangelo, 2004; Weiss, 2010)”
From Genetic and Dietary Iron Overload Differentially Affect the Course of Salmonella Typhimurium Infection (2017) · cites this paper as Pietrangelo, 2004
In the citing paper
“HH is characterized by reduced serum levels of the antimicrobial peptide Hamp (hepcidin) and increased duodenal absorption of iron via divalent metal transporter 1 (Dmt1) and ferroportin 1 (Fpn1) despite progressive iron overload in parenchymal organs including the liver, pancreas, and heart (Zoller et al., 1999, 2001; Bridle et al., 2003; Pietrangelo, 2004; Bardou-Jacquet et al., 2013).”
From Genetic and Dietary Iron Overload Differentially Affect the Course of Salmonella Typhimurium Infection (2017) · cites this paper as Pietrangelo, 2004
In the citing paper
“Hfe deficiency results in reduced Hamp production and increased serum iron levels (Pietrangelo, 2004).”
From Genetic and Dietary Iron Overload Differentially Affect the Course of Salmonella Typhimurium Infection (2017) · cites this paper as Pietrangelo, 2004
In the citing paper
“The proximal region of the human ferritin H gene was activated by NF-Y and p300 during hemin-induced FLC differentiation, and this proximal region was also responsible for cAMP (80, 194, 248).”
From Intracellular iron transport and storage: from molecular mechanisms to health implications (2008) · cites this paper as [248]
Citations
Cites
A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis
Feder, J. N., Gnirke, A., Thomas, W., Tsuchihashi, Z., Ruddy, D. A., Basava, A., Dormishian, F., Domingo, R., Ellis, M. C., Fullan, A., et al. (1996) · Nature Genetics · doi:10.1038/ng0896-399 · Cited by 3,664
Hepcidin, a urinary antimicrobial peptide synthesized in the liver
Park, C. H., Valore, E. V., Waring, A. J., & Ganz, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008922200 · Cited by 2,168
Mutation nomenclature extensions and suggestions to describe complex mutations: A discussion
den Dunnen, J. T., & Antonarakis, S. E. (2000) · Human Mutation · doi:10.1002/(sici)1098-1004(200001)15:1 · Cited by 1,757
Pigeon, C., Ilyin, G., Courselaud, B., Leroyer, P., Turlin, B., Brissot, P., & Loréal, O. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008923200 · Cited by 1,697
Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation
Ganz, T. (2003) · Blood · doi:10.1182/blood-2003-03-0672 · Cited by 1,544
Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein
Nemeth, E., Valore, E. V., Territo, M., Schiller, G., Lichtenstein, A., & Ganz, T. (2003) · Blood · doi:10.1182/blood-2002-10-3235 · Cited by 1,417
LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity
Krause, A., Neitz, S., Mägert, H.-J., Schulz, A., Forssmann, W.-G., Schulz-Knappe, P., & Adermann, K. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01920-7 · Cited by 1,324
Survival and Causes of Death in Cirrhotic and in Noncirrhotic Patients with Primary Hemochromatosis
Niederau, C., Fischer, R., Sonnenberg, A., Stremmel, W., Trampisch, H. J., & Strohmeyer, G. W. (1985) · New England Journal of Medicine · doi:10.1056/nejm198511143132004 · Cited by 1,063
Mutations in HFE2 cause iron overload in chromosome 1q–linked juvenile hemochromatosis
Papanikolaou, G., Samuels, M. E., Ludwig, E. H., MacDonald, M. L. E., Franchini, P. L., Dubé, M.-P., Andres, L., MacFarlane, J., Sakellaropoulos, N., Politou, M., et al. (2004) · Nature Genetics · doi:10.1038/ng1274 · Cited by 974
Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis
Roetto, A., Papanikolaou, G., Politou, M., Alberti, F., Girelli, D., Christakis, J., Loukopoulos, D., & Camaschella, C. (2003) · Nature Genetics · doi:10.1038/ng1053 · Cited by 860
Research works printed but not linked: 10
- Troisier M, 1871, Bull Soc Anat Paris, 44, 231
- von Recklinghausen FD, 1889, Tageblatt Versammlung Dtsche Naturforscher Arzte Heidelberg, 62, 324
- Sheldon JH. Haemochromatosis. London: Oxford University Press, 1935.
- Simon M, 1975, Nouv Presse Med, 4, 1432
- Simon M, 1987, Am J Hum Genet, 41, 89
- Cook JD, 1973, Am J Pathol, 72, 337
- Smith PM, 1969, Clin Sci, 37, 519
- McLaren GD, 1991, J Lab Clin Med, 117, 390
- Powell LW, 2002, Semin Gastrointest Dis, 13, 80
- Hayashi A, 1993, Am J Hum Genet, 53, 201
Cited by
Sorted by citations
Items 801–900 of 991
Diseases of Mineral Metabolism
Szeimies, R., & Dirschka, T. (2020) · Springer eBooks · doi:10.1007/978-3-662-58713-3_96-1 · Cited by 1
Ghaderi, A., Ahmadi, M. R. H., Hosseini, E., Akbari, A. A. M., Feizi, A. A. H., Hiradfar, A., & Hagh, M. F. (2016) · Comparative Clinical Pathology · doi:10.1007/s00580-016-2359-1 · Cited by 1
RetractedIron-Regulatory Function of Hepcidin in the Channel Catfish and Western Clawed Frog
Hu, X. (2008) · Cited by 1
Tendler, D. A. (2006) · doi:10.1002/9780470751541.ch11 · Cited by 1
Ironed Out: A Bacterial Siderophore Primer
Lakes, A. L., Rees, J. A., & Abergel, R. J. (2019) · Wiley eBooks · doi:10.1002/9781119951438.eibc2627 · Cited by 1
Chronic iron intoxication as an occupational disease
Lubyanova, I. P. (2005) · Ukrainian Journal of Occupational Health · doi:10.33573/ujoh2005.02.003 · Cited by 1
Cirrhosis and Portal Hypertension: Pathologic Aspects
WANG, H. L., & BRUNT, E. M. (2007) · Elsevier eBooks · doi:10.1016/b978-1-4160-3256-4.50107-1 · Cited by 1
Storage and Deposition Diseases
Gordon, D. A. (2008) · Springer eBooks · doi:10.1007/978-0-387-68566-3_68 · Cited by 1
Niederau, C. (2019) · Encyclopedia of Gastroenterology · doi:10.1016/b978-0-12-801238-3.65718-5 · Cited by 1
Directions for clinical practice improvement in HFE gene mutation testing
Gillett, M. J., Mamotte, C. D. S., Ravine, D., & Vasikaran, S. D. (2007) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2007.tb01277.x
Ghaderi, A., Ahmadi, M. R. H., Hosseini, E., Akbari, A. A. M., Feizi, A. A. H., Hiradfar, A., & Hagh, M. F. (2015) · Comparative Clinical Pathology · doi:10.1007/s00580-015-2156-2
RetractedEvangelista, A. S. (2013) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2013.tde-01082013-134115
Dietary advice in HFE-hemochromatosis
van Doorn, G. M., & Gosselink, I. M. G. (2012)
Genetic polymorphisms in bovine ferroportin are associated with beef iron content
Duan, Q. (2010) · Iowa State University Digital Repository (Iowa State University) · doi:10.31274/etd-180810-262
Micronutrients, Trace Elements
Cousins, R. J. (2006) · Wiley-VCH eBooks · doi:10.1002/3527600906.mcb.200400037
Non-Neoplastic Hepatobiliary Disease
Saxena, R., Blaszyk, H., & Batts, K. P. (2006) · Humana Press eBooks · doi:10.1007/978-1-60327-173-8_37
Mañaricúa, Z., & Fabiola, R. (2011) · Universidad de Chile
Iron Homeostasis: Hepcidin Regulation
Camaschella, C., & Silvestri, L. (2004) · Wiley eBooks · doi:10.1002/9781119951438.eibc2131
Taylor, R. M., & Corbani, T. (2009) · doi:10.1002/9781444322682.ch12
Guichelaar, M. M. J., & Charlton, M. (2012) · doi:10.1002/9781444398441.ch9
FAT1 expression and function in chronic liver disease and hepatocellular carcinoma
Valletta, D. (2014) · University of Regensburg Publication Server (University of Regensburg) · doi:10.5283/epub.28202
Xu, W. (2015) · DukeSpace (Duke University)
Porphyria Cutanea Tarda and HFE Gene Mutations in Argentina
Federico, C., Javier, M., Varela, L. S., Gerez, E. N., Manuel, M., Batlle, A. M. D. C., María, V. R., & Victoria, E. P. (2013) · Journal of Advances in Medicine and Medical Research · doi:10.9734/bjmmr/2014/7303
ESTUDO DO CONTROLO PÓS-TRANSCRICIONAL DA HEMOJUVELINA E SUA INFLUÊNCIA NA HOMEOSTASE DO FERRO
Tomé, F. (2010) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Molecular-Genetic Testing in Hepatocellular Carcinoma and Its Premalignant Conditions
Shackelford, R. E., Mayhall, G., Japa, S., Nasir, A., Malafa, M. P., & Coppola, D. (2013) · Springer eBooks · doi:10.1007/978-94-007-7192-5_7
Monteiro, E., Freire, A., Martins, A., & Barroso, E. (2008) · Elsevier eBooks · doi:10.1016/b978-84-8086-310-0.50038-5
Waluga, R. (2009) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-17363
Um caso de hemocromatose primária
de Família, M., & Nunes, C. (2010) · Revista Portuguesa de Clínica Geral · doi:10.32385/rpmgf.v26i6.10796
Véliz, M. A., Balverdi, M. D. P., Rodríguez, R. R., Villamil, F., & Sales, A. M. (2012) · Redalyc (Universidad Autónoma del Estado de México)
Zebrafish Models of Heme Synthesis and Iron Metabolism
Fraenkel, P. G. (2011) · Humana Press eBooks · doi:10.1007/978-1-60327-485-2_31
Dietary factors influencing non-heme iron absorption
Bonsmann, S. S. G. (2007) · Repository for Publications and Research Data (ETH Zurich) · doi:10.3929/ethz-a-005332658
Enfermedades hep?ticas de origen metab?lico
Alonso, M. L. M., Fernndez, M. C. S., la Vega, H. G. T., & Villarn, L. G. (2008) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0211-3449(08)73130-8
Trent, R. J. (2005) · Elsevier eBooks · doi:10.1016/b978-012699057-7/50003-5
Investigations of Potential Modifier Genes in Hereditary Haemochromatosis
Brew, J. (2010) · ANU Open Research (Australian National University) · doi:10.25911/5d7a265387fd8
Booley, F. (2007) · SUNScholar (Stellenbosch University)
In-vitro-Diagnostik systemischer Autoimmunkrankheiten
Genth, E., Mierau, R., & Michels, H. (2005) · Elsevier eBooks · doi:10.1016/b978-343721311-3.50064-1
Crawford, D. H., Fletcher, L. M., Anderson, G. J., Kowdley, K. V., McCaughan, G. W., & Trautwein, C. (2008) · Hepatology · doi:10.1002/hep.22427
A presentation of stage 2 HFE haemochromatosis in a young woman with epilepsy
Mougiou, A., Lempousi, D., & Καρακάντζα, Μ. (2007) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2007.10.007
Iron overload (with attention to genetic testing and diagnosis/management of HFE wild type patients)
Siddaiah, N. B., & Kowdley, K. V. (2006) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-006-0001-z
Filho, P. J. S., Kanaan, S., Xavier, A. R., Henriques, H. N., Pantaleão, J. A. S., & Guzmán-Silva, M. A. (2012) · Jornal Brasileiro de Patologia e Medicina Laboratorial · doi:10.1590/s1676-24442012000300005
A complex clinical case linking genetic disorders and infectious disease
Iorio, L. D., Lembo, E. D., Toscano, M., & Mezzetti, A. (2007) · Internal and Emergency Medicine · doi:10.1007/s11739-007-0085-z
Fenotipo, genotipo e historia de las enfermedades de sobrecarga de hierro
Rueda, A. D. C., & Khosravi‐Shahi, P. (2006) · Medicina Clínica · doi:10.1157/13087847
Muerte súbita y hemocromatosis
Abad, D., Ruiz, F. J. R., Ballarín, S. M., & Barcos, A. M. (2007) · Revista Clínica Española · doi:10.1016/s0014-2565(07)73327-1
Hemocromatosis. nuevos aspectos clínicos y diagnósticos
Altés, A. (2008) · Gaceta Médica de Bilbao · doi:10.1016/s0304-4858(08)74633-x
Steiner, M. L., & von Ahsen, N. (2005) · Der Klinikarzt · doi:10.1055/s-2005-865190
Hereditary haemochromatosis in a man of Pakistani descent
Morris, E. A., Rees, G., & Gorard, S. A. C. (2012) · QJM · doi:10.1093/qjmed/hcs018
Enfermedades hepáticas de origen metabólico
Fábrega, E., Pun, M. Á. M., Yudego, I. M., & Romero, F. P. (2012) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0304-5412(12)70353-0
Kerlan, V. (2008) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(08)74924-1
Ko, J. Y. P., Sham, T., Chakrabarti, S., & Adams, P. C. (2009) · Journal of Physics Conference Series · doi:10.1088/1742-6596/190/1/012207
Nagayoshi, Y. (2011) · Springer eBooks · doi:10.1007/978-1-4419-1795-9_125
Sikorska, K. (2012) · Hepatitis Monthly · doi:10.5812/hepatmon.5128
Pontes, C. N. R., & Caldas, G. (2013)
Ryan, J. D., Ryan, E. M., & Crowe, J. (2010) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.110.936583
Session 2: Personalised nutrition Genetic variation and disease risk: new advances
Scott, J. M. (2009) · Proceedings of The Nutrition Society · doi:10.1017/s0029665109001037
Osteoporosis in an elderly man as interplay of multiple diseases
Foppiani, L., Cella, A., Carrara, P., Balocco, M., Forzano, F., Leone, D., Ivaldi, G., Bacigalupo, L., & Monte, P. D. (2010) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/j.1447-0594.2010.00648.x
Hereditary Hemochromatosis and Iron Overload
Niederau, C. (2009) · Springer eBooks · doi:10.1007/978-3-642-04519-6_28
Hepatocellular Carcinoma Arising in the Non-viral, Non-alcoholic Liver
Woodall, C. E., Martin, R. C. G., McMasters, K. M., & Scoggins, C. R. (2010) · Springer eBooks · doi:10.1007/978-1-60327-522-4_8
Treatments for hereditary haemochromatosis: a network meta-analysis
Gurusamy, K. S., Tsochatzis, E. A., Thorburn, D., & Davidson, B. R. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011647
Reinstrup, P., Ryding, E., Ohlsson, T., Sandell, A., Erlandsson, K., Ljunggren, K., Salford, L. G., Strand, S., & Uski, T. K. (2008)
Davis, C. F., & Dorak, M. T. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6752-7_17
Storage Disorders in Hematology
Munker, R. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-149-9_23
Hereditary hemochromatosis and alcohol: pathogenic synergism - a clinical case
Vizinho, R., Girones, C., Loureiro, R., & Namora, J. (2008) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Teixeira, L., Duarte, D., & Saraiva, R. Â. (2009)
Hämatologie, Onkologie und Gerinnungsstörungen
Zoller, H., Schranz, M., Pechlaner, C., Hetzenauer, G., Pall, C., Galvan, O., Willenbacher, W., & Gastl, G. A. (2010) · Springer eBooks · doi:10.1007/978-3-211-88900-8_13
Valković, T., Petranović, D., Načinović-Duletić, A., & Host, I. (2010) · Medicina Fluminensis
Imoto, S., Sakurai, K., Sugimoto, T., Hashimoto, M., Saigo, K., Akita, S., Araki, N., Yamashita, M., Namura, K., Bouike, Y., et al. (2010) · Japanese Journal of Transfusion and Cell Therapy · doi:10.3925/jjtc.56.697
Thuret, I., Fossat, C., & Perrimond, H. (2006) · EMC - Pédiatrie - Maladies infectieuses · doi:10.1016/s1637-5017(06)74490-8
Kawanaka, M., Nakamura, J., Oka, Y., Kimura, T., Goto, D., Yamato, R., Nishino, K., Suehiro, M., Kawamoto, H., Yamada, G., et al. (2011) · Kanzo · doi:10.2957/kanzo.52.745
Genetisch bedingte Hämochromatose
Stremmel, W. (2007) · Die Gastroenterologie · doi:10.1007/s11377-007-0074-9
Syndrome endocrinien de l'hémochromatose idiopathique
Sonnet, E., & Kerlan, V. (2006) · EMC - Endocrinologie - Nutrition · doi:10.1016/s1155-1941(06)40972-0
Hepcidin knockout mice as a model of iron-overload associated liver disease
Lunová, M., Vaulont, S., Haybaeck, J., Lackner, K., Adler, G., & Strnad, P. (2011) · Zeitschrift für Gastroenterologie · doi:10.1055/s-0030-1269571
of Hepatic Fat and Iron with Magnetic Resonance Imaging
Wells, S. A. (2014)
Fang, H., Wu, Y., Yoon, M. S., Jiménez-Barrón, L. T., O'Rawe, J., Highnam, G., Mittelman, D., & Lyon, G. J. (2015) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/019182
Vieira, F. D. T., Hardt, I., Rangel, M. C. V., Flecher, M. C., & Rossi, J. L. (2015)
Disorders of Iron MetabolismProgress in Hematology
Domenico, I. D., Ward, D. M., Musci, G., & Kaplan, J. (2006)
Could 18F-FDG PET Be a Diagnostic Tool for Hemochromatosis?
Zanella, I., Bertagna, F., & Biasiotto, G. (2015) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000001070
Hemokromatosia. alderdi kliniko eta diagnostiko berriak
Altés, A. (2008) · Gaceta Médica de Bilbao
Genetisch bedingte Stoffwechselerkrankungen des Gastrointestinaltrakts
Stremmel, W., Merle, U., Stölzel, U., & Manfred Otto, D. O. S. S. (2015) · Springer eBooks · doi:10.1007/978-3-642-14301-4_41
Metabolic Genetic DisordersWith Prominent Skin Findings
Mizelle, C. B., & Goldsmith, L. A. (2007) · Humana Press eBooks · doi:10.1007/978-1-59259-963-9_109
Role of iron in ethanol derived hepatic stress
Thornton, J. A. (2013)
Jereza, N. A. (2016) · UWE Research Repository (UWE Bristol)
REVISTA ARGENTINA de DERMATOLOGÍA REVISTA ARGENTINA de DERMATOLOGÍA
Dermatol, R. A. (2007)
Valutazione del rischio genetico
Korf, B. R. (2009) · Springer eBooks · doi:10.1007/978-88-470-1150-2_14
Sánchez, W. (2014) · doi:10.1093/med/9780199373338.003.0034
Hes, F. J., & Breuning, M. H. (2010) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-313-7361-1_4
Liver Transplantation for Hematological Disorders
Tap, W. D., & Marder, V. J. (2005) · Elsevier eBooks · doi:10.1016/b978-0-7216-0118-2.50022-7
Iron inhibits replication of infectious hepatitis C virus in permissive Huh7.5.1 cells
Davis, L., Mortimer, S., & Lynn, B. C. D. (2010)
Wang, Y., Du, Y., Liu, G., Guo, S., Yang, N., Hou, B., Jiang, X., Han, B., Chang, Y., & Nie, G. (2016) · Gene Reports · doi:10.1016/j.genrep.2016.10.010
Bosco, M. D. (2015) · Adelaide Research & Scholarship (AR&S) (University of Adelaide)
Metabolic and Genetic Liver Diseases: Hemochromatosis
Stotts, M. J., & Bacon, B. R. (2016) · Springer eBooks · doi:10.1007/978-3-319-30103-7_20
Clinical-Pathological Conference Series from the Medical University of Graz
Fabian, E., Schiller, D., Graninger, W. B., Langner, C., Frei, J., Schoellnast, H., Alibegovic, V., Stauber, R. E., Schoefl, R., & Krejs, G. J. (2016) · Wiener klinische Wochenschrift · doi:10.1007/s00508-016-1010-0
Metadata
- Authors
- Pietrangelo, A.
- Affiliations
- University of Modena and Reggio Emilia (IT)
- Corresponding author
- Pietrangelo, Antonello
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-06-03
- Volume
- 350
- Issue
- 23
- Pages
- 2383-2397
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2168051647
- Cited by
- 992
- References
- 97
- Citations by year
- 2026: 12 · 2025: 11 · 2024: 16 · 2023: 17 · 2022: 22 · 2021: 18 · 2020: 21 · 2019: 21 · 2018: 38 · 2017: 38 · 2016: 37 · 2015: 42 · 2014: 34 · 2013: 42 · 2012: 41
- FWCI
- 11.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Keywords
- hereditary hemochromatosis, HFE gene, iron overload, iron metabolism genes, disease management, diabetes mellitus, liver cirrhosis
- MeSH terms
- Hemochromatosis Protein, Genotype, Hemochromatosis, Homeostasis, Humans, Iron, Membrane Proteins, Mutation, Phenotype, Receptors, Transferrin, Histocompatibility Antigens Class I, Iron Overload, Antimicrobial Cationic Peptides, Hepcidins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review